医院常见抗感冒中成药临床用药分析

摘要

目的 对临床选用抗感冒药进行分析总结,指导临床用药.方法 收集深圳市龙岗中心医院2010年7月至2012年7月感冒患者病历资料436例,并进行回顾性分析.结果 436例病历资料中涉及中成药884种,其中风寒感冒药101种(1 1.4％),以使用感冒清热软胶囊者为主,占52.6％(229例);风热感冒药417种(47.2％),以使用风热感冒颗粒和银翘解毒片者为主,分别占38.7％(169例)和30.3％(132例);暑湿感冒药250种(28.3％),以使用藿香正气水及相关剂型者为主,占88.1％(384例);体虚感冒药72种(8.1％),使用参苏宣肺丸与玉屏风颗粒者所占比例分别为43.6％(190例)和45.4％(198例);时行感冒药44种(5.0％),以使用清热解毒口服液者为主,占82.6％(360例).结论 合理选用抗感冒中成药物,可有效保证临床疗效.%Objective To analyze and summarize clinical anti-cold drugs to guide clinical practice.Methods A total of 436 cases of cold were collected from July 2010 to July 2012 and were analyzed retrospectively.Results Eight hundred and eighty-four kinds of Chinese medicine were involved,including 101 kinds of anemofrigid cold medicines (11.4％).Ganmaoqing soft capsule accounted for 52.6％ (229 cases) ; 417 kinds of anemopyretic cold medicine (47.2％) were mainly Fengreganmao granules and Yinqiao Jiedu tablet [38.7％ (169 cases) and 30.3％ (132 cases)] ; 250 kinds of Damp cold medicine(28.3％),Huoxiang Zhengqi liquid and related forms accounted for 88.4％ (384 cases) ; 72 kinds of Tixu cold medicine(8.1％)included Shen Su Xuanfei pill and Yuping wind particles; 44 kinds of epidemic cold medicine(5.0％)were mainly Qingrejiedu oral liquid [82.6％ (360 cases)].Conclusion Rational anti-cold Chinese patent drug can effectively ensure clinical efficacy.